Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

NCT07335328

Conditions: B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not Yet Recruiting

Axatilimab + CAR-T for High-Risk Lymphoma

NCT07638982

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Digestive System Diseases, Follicular Grade 3 Lymphoma, +21 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Not Yet Recruiting

TR115 VS Investigator's Choice in Relapsed/Refractory Peripheral T/NK Cell Lymphoma

NCT07639879

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +5 more
Locations: Peking University Cancer Hospital Beijin, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

NCT07637929

Conditions: Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment

NCT07636564

Conditions: Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, +24 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

NCT07634289

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Townsville University Hospital Douglas, Queensland, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Flinders Medical Centre Bedford Park, South Australia, Australia

Austin Hospital Heidelberg, Victoria, Australia

View Trial Details

Not Yet Recruiting

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

NCT07021989

Conditions: Classic Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
Locations: University of California Davis Davis, California, United States

University of California San Francisco-Fresno Fresno, California, United States

University of California Irvine Irvine, California, United States

University of California, San Diego La Jolla, California, United States

View Trial Details

Not Yet Recruiting

Pirtobrutinib Maintenance After CAR-T Therapy in Relapsed or Refractory B-Cell Lymphoma

NCT07622784

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia

NCT07623655

Conditions: Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma

NCT07615283

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions